Schahram Akbarian, MD, PhD
img_Schahram Akbarian
PROFESSOR | Genetics and Genomic Sciences
PROFESSOR | Psychiatry
PROFESSOR | Neuroscience
Research Topics
Depression, Schizophrenia
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Dr. Akbarian’s research interests include epigenetic determinants of normal and diseased human brain development, with implications for the neurobiology of major psychiatric disorders such as schizophrenia, autism and depression. This work is largely focused on charting DNA and histone modification landscapes, and more generally, genome organization, in specific cell types from brain. These clinical studies are complemented by preclinical research, exploring novel avenues for treatment of psychiatric disease in cell cultures and animal models with specific mutations in proteins regulating chromatin and chromosomal architectures.

Key words: nucleosome, epigenome, histone methylation, neuronal nucleus, prefrontal cortex, mood disorder, schizophrenia, autism spectrum disorder
Publications

Selected Publications

Functional implications of polygenic risk for schizophrenia in human neurons. P. J. Michael Deans, Kayla G. Retallick-Townsley, Aiqun Li, Carina Seah, Jessica Johnson, Judit Garcia Gonzalez, Evan Cao, Nadine Schrode, Alex Yu, Sam Cartwright, Georgios Voloudakis, Wen Zhang, Minghui Wang, John F. Fullard, Kiran Girdhar, Eli Stahl, Schahram Akbarian, Bin Zhang, Panos Roussos, Paul O’Reilly, Laura M. Huckins, Kristen J. Brennand. Nature Communications

Transcriptional impacts of substance use disorder and HIV on human ventral midbrain neurons and microglia. Alyssa M. Wilson, Michelle M. Jacobs, Tova Y. Lambert, Aditi Valada, Gregory Meloni, Evan Gilmore, Jacinta Murray, Susan Morgello, Schahram Akbarian. Nature Communications

A map of enhancer regions in primary human neural progenitor cells using capture STARR-seq. Sophia C. Gaynor-Gillett, Lijun Cheng, Manman Shi, Jason Liu, Gaoyuan Wang, Megan Spector, Qiuyu Guo, Le Qi, Mary Flaherty, Martha Wall, Ahyeon Hwang, Mengting Gu, Zhanlin Chen, Yuhang Chen, Jennifer R. Moran, Jing Zhang, Donghoon Lee, Mark Gerstein, Daniel H. Geschwind, Kevin P. White, Schahram Akbarian, Alexej Abyzov, Nadav Ahituv, Dhivya Arasappan, Jose Juan Almagro Armenteros, Brian J. Beliveau, Jaroslav Bendl, Sabina Berretta, Rahul A. Bharadwaj, Arjun Bhattacharya, Lucy Bicks, Kristen Brennand, Davide Capauto, Frances A. Champagne, Tanima Chatterjee, Chris Chatzinakos, Andrew Chess, Nikolaos P. Daskalakis, John F. Fullard, Kiran Girdhar, Vahram Haroutunian, Gabriel E. Hoffman, Alex Kozlenkov, Dalila Pinto, Towfique Raj, Panos Roussos, Robert Sebra, Harm van Bakel, Georgios Voloudakis, Biao Zeng. Genome Research

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Akbarian has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.